Clinical Trial Update: A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for disitamab vedotin in locally advanced or metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Disitamab Vedotin (disitamab vedotin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN